Literature DB >> 20116963

Relationship between anxiety disorders and opiate dependence--a systematic review of the literature: implications for diagnosis and treatment.

Melina Fatséas1, Cécile Denis, Estelle Lavie, Marc Auriacombe.   

Abstract

Our objective was to evaluate the prevalence and temporal sequence of co-occurrence of anxiety disorders with opiate dependence in order to better define the relationship between these two disorders and to improve diagnosis and treatment. The search used Medline and Toxibase up to January 1, 2009, and was based on a systematic review method. Eighteen studies were found. Prevalence of anxiety disorders assessed by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria was high in opiate-dependent treated persons (lifetime prevalence ranged from 26% to 35%). Among anxiety disorders, phobic disorders have been shown to often precede the onset of opiate dependence. The identification of substance-induced versus independent anxiety disorder has important treatment implication. The monitoring of anxiety symptoms after several weeks of abstinence may allow physicians to determine the relationship between dependence and anxiety and make a reliable diagnosis of any initial anxious disorder. Specific management of anxiety disorder may then be used. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20116963     DOI: 10.1016/j.jsat.2009.12.003

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  15 in total

Review 1.  Treatment of substance abusing patients with comorbid psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  Addict Behav       Date:  2011-09-14       Impact factor: 3.913

2.  Longitudinal investigation of the impact of anxiety and mood disorders in adolescence on subsequent substance use disorder onset and vice versa.

Authors:  Kate Wolitzky-Taylor; Lyuba Bobova; Richard E Zinbarg; Susan Mineka; Michelle G Craske
Journal:  Addict Behav       Date:  2012-03-29       Impact factor: 3.913

3.  Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Dan G Blazer
Journal:  Drug Alcohol Depend       Date:  2010-07-01       Impact factor: 4.492

Review 4.  Exploring the comorbidity of anxiety and substance use disorders.

Authors:  Sonja Pasche
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

Review 5.  Anxiety and substance use disorders: co-occurrence and clinical issues.

Authors:  Florence Vorspan; Wajdi Mehtelli; Gaël Dupuy; Vanessa Bloch; Jean-Pierre Lépine
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

6.  Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.

Authors:  Paula E Park; Leandro F Vendruscolo; Joel E Schlosburg; Scott Edwards; Gery Schulteis; George F Koob
Journal:  Int J Neuropsychopharmacol       Date:  2013-04-16       Impact factor: 5.176

7.  Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol.

Authors:  Jérôme A J Becker; Brigitte L Kieffer; Julie Le Merrer
Journal:  Addict Biol       Date:  2016-04-28       Impact factor: 4.280

Review 8.  Integrated treatment of substance use and psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley
Journal:  Soc Work Public Health       Date:  2013

Review 9.  Treatment for Substance Use Disorder With Co-Occurring Mental Illness.

Authors:  Muhammad N Iqbal; Charles J Levin; Frances R Levin
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-04-10

10.  Orbitofrontal sulcogyral morphology in patients with cocaine use disorder.

Authors:  Marisa A Patti; Sarah Wochele; Yirui Hu; Paul S Regier; Anna Rose Childress; Vanessa Troiani
Journal:  Psychiatry Res Neuroimaging       Date:  2020-09-02       Impact factor: 2.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.